medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 4

<< Back Next >>

Med Int Mex 2022; 38 (4)

Guillain-Barre syndrome during arboviral outbreaks in Mexico

del Carpio-Orantes L

Language: Spanish
References: 14
Page: 820-824
PDF size: 202.65 Kb.


ABSTRACT

Objective: To perform a search of studies done at Mexican Republic with the purpose of having more information about cases of Guillain-Barre syndrome associated to arboviral outbreaks.
Methodology: A systematic review of the Guillain-Barré syndrome cohorts reported in the Mexican Republic from 2015 to 2018 was carried out, making the search in the main search engines: Web of science, Pubmed-Medline, Scopus, Google scholar, Redalyc, Science direct, Scielo and Imbiomed. The items used were: Zika, outbreak, Guillain-Barre syndrome, Mexico.
Resultados: After the systematic review, only 4 studies reported in Mexico were found, 2 corresponding to 2016, 2 to 2017 and another that included patients from 2016 to 2018. Campylobacter stood out as the main etiological agent of the syndrome in two studies, one conducted in northwest of Mexico (Ensenada, Baja California) and another in the southeast (Veracruz); the global incidence of this agent was 20%. The incidence of Zika as the causative agent of Guillain-Barré syndrome was 18%.
Conclusions: The main etiological agent of Guillain-Barre syndrome in Mexico is Campylobacter, despite the cases reported during arboviral outbreaks, highlighting the reiteration of the results in both the northwest and the southeast of the country.


REFERENCES

  1. Leonhard SE, Mandarakas MR, Gondim FAA, BatemanK, et al. Diagnosis and management of Guillain–Barrésyndrome in ten steps. Nat Rev Neurol 2019; 15: 671-683.doi:10.1038/s41582-019-0250-9.

  2. Del Carpio-Orantes, L, Sánchez-Díaz, JS. Guillain Barré Syndrome,before and after Zika. J Neurosci Rural Pract 2019;10 (3): 567-568. doi: 10.1055/s-0039-1697564.

  3. Dos Santos T, Rodriguez A, Almiron M, Sanhueza A, RamonP, De Oliveira WK, et al. Zika virus and the Guillain-Barresyndrome—Case series from seven countries. N Engl J Med2016; 375 (16): 1598-601.

  4. Del Carpio-Orantes L. Síndrome de Guillain-Barré asociadoa zika, experiencia americana. Estudio bibliométrico. Neurología2017. https://doi.org/10.1016/j.nrl.2018.05.001.

  5. Barbi L, Coelho AVC, Alencar LCA de, Crovella S. Prevalenceof Guillain-Barré syndrome among Zika virus infectedcases: a systematic review and meta-analysis. Brazilian JInfect Dis 2018; 22 (2): 137-41. https://doi.org/10.1016/j.bjid.2018.02.005.

  6. Capasso A, Ompad DC, Vieira DL, Wilder-Smith A, Tozan Y.Incidence of Guillain-Barré syndrome (GBS) in Latin Americaand the Caribbean before and during the 2015-2016Zika virus epidemic: A systematic review and meta-analysis.PLOS Neglected Tropical Diseases 2019; 13 (8): e0007622.https://doi.org/10.1371/journal.pntd.0007622.

  7. Casos confirmados de enfermedad por virus del Zika, Semanaepidemiológica 50 del 2019. Fuente: SINAVE/DGE/SS: Sistema de Vigilancia Epidemiológica de Enfermedadpor virus del Zika. https://www.gob.mx/cms/uploads/attachment/file/518441/Cuadro_Casos_ZIKA_y_Emb_sem_50_2019.pdf.

  8. Casos confirmados de Síndrome de Guillain-Barré asociadoa Zika en México. Fuente: SINAVE/DGE/SS: Sistemade Vigilancia Epidemiológica de Enfermedad por virusdel Zika. Actualizado al 6 de febrero de 2018. https://www.gob.mx/cms/uploads/attachment/file/390724/ZIKA_SxGB_060218.pdf.

  9. Del Carpio-Orantes L, Sánchez-Díaz JS, Peniche-Moguel KG,et al. Guillain Barré syndrome in arbovirus outbreak in Veracruz,Mexico: The follow-up to 3 years of the pandemic.Open Forum Infectious Diseases 2019; 6 (Supplement 2):S615. https://doi.org/10.1093/ofid/ofz360.1544.

  10. Ramírez-Rayón EM, Ávalos-Ríos JM, García-Jiménez FJ,Blancas-Cervantes JM, et al. Síndrome de Guillain-Barréconcomitante con infección por virus Zika. Med Int Méx2018; 34 (5): 667-677. DOI: https://doi.org/10.24245/mim.v34i5.1778.

  11. Soto-Hernández J, Ponce de León-Rosales S, Vargas-CañasE, Cárdenas G, et al. Guillain-Barré syndrome associatedwith Zika virus infection: a prospective case seriesfrom Mexico. Front Neurol 2018; 10: 435. doi:10.3389/fneur.2019.00435.

  12. Romero-Salas MT, Teresa F, Arzate F, Garcia A, et al.Guillain-Barré outbreak study in Ensenada, Baja California,Mexico. J Vaccines Vaccin 2018; 9: 66. DOI: 10.4172/2157-7560-C1-063

  13. Góngora-Rivera F, Grijalva I, Infante-Valenzuela A, Camara-Lemarroy C, et al. Zika virus infection and Guillain-Barrésyndrome in Northeastern Mexico: A case-control study.PLoS One 2020; 15 (3): e0230132. doi:10.1371/journal.pone.0230132

  14. Rodríguez-Morales AJ, Failoc-Rojas VE, Díaz-Vélez C. Gastrointestinal,respiratory and/or arboviral infections? Whatis the cause of the Guillain-Barré syndrome epidemics inPerú? Current status – 2019. Travel Med Infect Dis 2019;30: 114-116. doi: 10.1016/j.tmaid.2019.06.015.




2020     |     www.medigraphic.com